Lovvorn H N, Nance M L, Ferry R J, Stolte L, Baker L, O'Neill J A, Schnaufer L, Stanley C A, Adzick N S
Department of Surgery, The Children's Hospital of Philadelphia, The University of Pennsylvania School of Medicine, 19104, USA.
J Pediatr Surg. 1999 May;34(5):786-92; discussion 792-3. doi: 10.1016/s0022-3468(99)90374-3.
BACKGROUND/PURPOSE: Congenital hyperinsulinism induces severe and unremitting hypoglycemia in newborns and infants. If poorly controlled, seizures and irreversible brain damage may result. Subtotal (<95%) or near-total (95% to 98%) pancreatectomy have been performed for glycemic control in babies who do not respond to aggressive medical therapy. Because hypoglycemia often persists after subtotal resection, 95% pancreatectomy has emerged as the procedure of choice. To define the effect of more or less extensive pancreatectomy on the management and outcome of refractory congenital hyperinsulinism, the authors examined our single institutional experience.
The records of children treated between 1963 and 1998 for congenital hyperinsulinism, and who required pancreatectomy, were reviewed. Outcome parameters included glycemic response to surgery, need for reresection, surgical morbidity, surgical and long-term mortality, and development of diabetes mellitus (DM). A complete response was defined as discharge to home on no glycemic medications, no continuous feedings, and without DM. Histological reports were reviewed and categorized as either diffuse or focal disease.
Of 101 children treated for congenital hyperinsulinism during this period, 53 (50%) required pancreatectomy for glucose control. Mean follow-up for the study population was 9.8 +/- 1.1 years. Overall, 23 children (43%) showed a complete response, occurring in 50% of patients having > or = 95% pancreatectomy (n = 34), but in only 19% having less than 95% resection (n = 16). The remaining three babies had local excision of a solitary focal lesion, and each showed a complete response. Histopathology showed diffuse islet abnormalities in 42 specimens (79%) and solitary focal lesions in 11 (21%). A complete response was observed for 82% of focal but only 33% of diffuse lesions. Eight patients (15%) required reresection for persistent hypoglycemia, seven having diffuse lesions and one focal. Surgical morbidity occurred in 13 cases (26%), and the 30-day surgical mortality rate was 6%, each death (n = 3) occurring before 1975. DM developed in seven children (14%), each having diffuse lesions, and was independent of resection type.
Because euglycemia is more readily restored, and because the risks for surgical complications and DM do not appear increased, the authors recommend 95% pancreatectomy as the initial procedure of choice for newborns and infants with congenital hyperinsulinism.
背景/目的:先天性高胰岛素血症可导致新生儿和婴儿出现严重且持续的低血糖。若控制不佳,可能引发癫痫和不可逆的脑损伤。对于积极药物治疗无效的婴儿,已采用次全胰腺切除术(切除<95%)或近全胰腺切除术(切除95%至98%)来控制血糖。由于次全切除术后低血糖往往持续存在,95%胰腺切除术已成为首选术式。为明确更广泛或不太广泛的胰腺切除术对难治性先天性高胰岛素血症治疗及预后的影响,作者回顾了我们单一机构的经验。
回顾了1963年至1998年间因先天性高胰岛素血症接受胰腺切除术的儿童记录。结局参数包括手术对血糖的反应、再次手术的需求、手术并发症、手术及长期死亡率,以及糖尿病(DM)的发生情况。完全缓解定义为出院时无需使用降糖药物、无需持续喂养且无糖尿病。回顾组织学报告并分类为弥漫性或局灶性疾病。
在此期间,101例接受先天性高胰岛素血症治疗的儿童中,53例(50%)因血糖控制需要进行胰腺切除术。研究人群的平均随访时间为9.8±1.1年。总体而言,23例儿童(43%)显示完全缓解,在胰腺切除≥95%的患者中占50%(n = 34),而在切除<95%的患者中仅占19%(n = 16)。其余3例婴儿对孤立的局灶性病变进行了局部切除,均显示完全缓解。组织病理学显示42份标本(79%)有弥漫性胰岛异常,11份标本(21%)有孤立性局灶性病变。局灶性病变的完全缓解率为82%,而弥漫性病变仅为33%。8例患者(15%)因持续性低血糖需要再次手术,7例为弥漫性病变,1例为局灶性病变。13例(26%)发生手术并发症,30天手术死亡率为6%,3例死亡均发生在1975年之前。7例儿童(14%)发生糖尿病,均为弥漫性病变,且与切除类型无关。
由于更容易恢复正常血糖,且手术并发症和糖尿病的风险似乎并未增加,作者推荐95%胰腺切除术作为先天性高胰岛素血症新生儿和婴儿的首选初始术式。